Rare diseases
Investigational molecules
Locations
Building G Espace Europeen, 15 Chemin Du Saquin, 69130 Ecully, France
Amolyt Pharma’s clinical research includes endocrine disorders with a focus on conditions affecting hormonal regulation and mineral balance, particularly acromegaly and hypoparathyroidism.
The sponsor’s portfolio reflects interest in therapeutic areas linked to abnormal growth hormone activity and disorders of calcium homeostasis.
Amolyt Pharma runs clinical trials in conditions such as Hypoparathyroidism, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
